New weight loss drug dubbed 'triple G' shows promise: What to know about retatrutide A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising results in new data released Thursday by its maker, Eli Lilly
Discover how we've helped countless clients feel healthier and more confident.
The Middle East and Africa's pharmaceutical industry is anticipated to expand due to the rising incidence of sedentary-related diseases like obesity, diabetes, thyroid, and heart disorders
A study in healthy volunteers explored the vasodilatory and headache-inducing properties of GLP-1, revealing no significant differences in post-infusion headache between GLP-1 and placebo [30]
Keeping a diary helps tailor meal timing and injection strategies
Ammonium contributes by suppressing aerobic respiration and promoting glycolysis through ammonia-mediated metabolic reprogramming, thereby exacerbating lactate accumulation and acidosis